Ghaith Abu‐Zeinah

909 total citations
44 papers, 254 citations indexed

About

Ghaith Abu‐Zeinah is a scholar working on Genetics, Rheumatology and Hematology. According to data from OpenAlex, Ghaith Abu‐Zeinah has authored 44 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 19 papers in Rheumatology and 17 papers in Hematology. Recurrent topics in Ghaith Abu‐Zeinah's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers), Eosinophilic Disorders and Syndromes (17 papers) and Acute Myeloid Leukemia Research (7 papers). Ghaith Abu‐Zeinah is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers), Eosinophilic Disorders and Syndromes (17 papers) and Acute Myeloid Leukemia Research (7 papers). Ghaith Abu‐Zeinah collaborates with scholars based in United States, United Kingdom and Qatar. Ghaith Abu‐Zeinah's co-authors include Joseph M. Scandura, Richard T. Silver, Maria T. DeSancho, Ellen K. Ritchie, Ghassan K. Abou‐Alfa, Clara Oromendia, Dwight H. Owen, James J. Harding, Nancy E. Kemeny and Guilherme H. Oliveira and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Leukemia.

In The Last Decade

Ghaith Abu‐Zeinah

35 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghaith Abu‐Zeinah United States 7 145 118 98 96 31 44 254
Xianghua Huang China 10 67 0.5× 61 0.5× 67 0.7× 180 1.9× 51 1.6× 32 309
Liwei Fang China 11 147 1.0× 44 0.4× 244 2.5× 108 1.1× 28 0.9× 31 329
Jonathan Lambert United Kingdom 9 115 0.8× 53 0.4× 69 0.7× 65 0.7× 61 2.0× 25 235
Özgür Mehtap Türkiye 11 51 0.4× 41 0.3× 73 0.7× 68 0.7× 58 1.9× 34 257
Chin Yang Li United States 7 188 1.3× 117 1.0× 148 1.5× 99 1.0× 33 1.1× 13 306
Kaoru Takase-Minegishi Japan 7 49 0.3× 178 1.5× 67 0.7× 31 0.3× 60 1.9× 11 287
M. Safy Netherlands 7 49 0.3× 240 2.0× 64 0.7× 28 0.3× 32 1.0× 10 375
Richard Murrin United Kingdom 5 190 1.3× 56 0.5× 146 1.5× 107 1.1× 22 0.7× 10 296
T. Tison Italy 8 133 0.9× 65 0.6× 109 1.1× 27 0.3× 16 0.5× 19 281
Yosuke Kunishita Japan 9 90 0.6× 212 1.8× 40 0.4× 76 0.8× 35 1.1× 20 308

Countries citing papers authored by Ghaith Abu‐Zeinah

Since Specialization
Citations

This map shows the geographic impact of Ghaith Abu‐Zeinah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghaith Abu‐Zeinah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghaith Abu‐Zeinah more than expected).

Fields of papers citing papers by Ghaith Abu‐Zeinah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghaith Abu‐Zeinah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghaith Abu‐Zeinah. The network helps show where Ghaith Abu‐Zeinah may publish in the future.

Co-authorship network of co-authors of Ghaith Abu‐Zeinah

This figure shows the co-authorship network connecting the top 25 collaborators of Ghaith Abu‐Zeinah. A scholar is included among the top collaborators of Ghaith Abu‐Zeinah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghaith Abu‐Zeinah. Ghaith Abu‐Zeinah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abu‐Zeinah, Ghaith, Anthony M. Hunter, Joseph J. Shatzel, et al.. (2025). Real-world analysis of polycythemia vera treatment reveals nonadherence to NCCN guidelines in a large proportion of patients. PubMed. 2(4). 100167–100167.
2.
Yacoub, Abdulraheem, Ghaith Abu‐Zeinah, Albert Qin, et al.. (2025). PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera. Annals of Hematology. 104(1). 335–345.
3.
Choi, Daniel, Ghaith Abu‐Zeinah, Pouneh Kermani, et al.. (2024). JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms. Leukemia. 38(11). 2487–2491. 4 indexed citations
4.
Savenkov, Oleksandr, et al.. (2024). Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes. Blood Advances. 8(10). 2520–2526. 4 indexed citations
5.
Choi, Daniel, Ghaith Abu‐Zeinah, Pouneh Kermani, et al.. (2024). Hematopoietic Bias Drives Lymphopenia in Myeloproliferative Neoplasms. Blood. 144(Supplement 1). 1764–1764. 1 indexed citations
6.
Abu‐Zeinah, Ghaith, et al.. (2024). High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera. Blood Advances. 9(6). 1320–1329. 2 indexed citations
7.
Abu‐Zeinah, Ghaith, et al.. (2024). DNMT3A Mutations Do Not Affect Treatment Response or Outcomes for Patients with Polycythemia Vera Treated with Interferon Alpha. Blood. 144(Supplement 1). 3190–3190. 1 indexed citations
8.
9.
Abu‐Zeinah, Ghaith, Silvana Di Giandomenico, Daniel Choi, et al.. (2022). Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome. Blood Advances. 6(18). 5477–5481. 4 indexed citations
10.
Choi, Daniel, et al.. (2022). JAK2 V617F Impairs T Cell Differentiation in Polycythemia Vera. Blood. 140(Supplement 1). 6746–6747. 1 indexed citations
11.
Scandura, Joseph M., et al.. (2022). Polycythemia Vera Molecular Response and Its Correlation with Disease Progression: A Systematic Review and Meta-Analysis. Blood. 140(Supplement 1). 3993–3994. 1 indexed citations
12.
Abu‐Zeinah, Ghaith, Richard T. Silver, Douglas Tremblay, et al.. (2021). A Novel Machine Learning-Derived Dynamic Scoring System Predicts Risk of Thrombosis in Polycythemia Vera (PV) Patients. Blood. 138(Supplement 1). 3619–3619. 3 indexed citations
13.
Abu‐Zeinah, Ghaith, et al.. (2021). Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival. Leukemia. 35(9). 2592–2601. 61 indexed citations
14.
Abu‐Zeinah, Ghaith, et al.. (2021). Normal life expectancy for polycythemia vera (PV) patients is possible. Leukemia. 36(2). 569–572. 26 indexed citations
15.
Abu‐Zeinah, Ghaith, et al.. (2021). Normal Life Expectancy for Polycythemia Vera Patients Is Possible. Blood. 138(Supplement 1). 2575–2575. 2 indexed citations
16.
Giandomenico, Silvana Di, Pouneh Kermani, Ghaith Abu‐Zeinah, et al.. (2020). Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors. Blood. 136(9). 1044–1054. 11 indexed citations
17.
Abu‐Zeinah, Ghaith, et al.. (2020). Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Harding, James J., Ghaith Abu‐Zeinah, Joanne F. Chou, et al.. (2018). Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma. Journal of the National Comprehensive Cancer Network. 16(1). 50–58. 39 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianghua Huang Breakdown of academic impact, for papers by Liwei Fang Breakdown of academic impact, for papers by Jonathan Lambert Breakdown of academic impact, for papers by Özgür Mehtap Breakdown of academic impact, for papers by Chin Yang Li Breakdown of academic impact, for papers by Kaoru Takase-Minegishi Breakdown of academic impact, for papers by M. Safy Breakdown of academic impact, for papers by Richard Murrin Breakdown of academic impact, for papers by T. Tison Breakdown of academic impact, for papers by Yosuke Kunishita
Rankless by CCL
2026